Rikke Andersen

Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line

Carsten Uhd Nielsen, Rikke Andersen, Birger Brodin et al. · Journal of Controlled Release · 2001 · 65 citations

Dipeptide Model Prodrugs, Molecular Pharmacology, Molecular Physiology +8

Evaluation of the Permeation Characteristics of a Model Opioid Peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and Its Cyclic Prodrugs across the Blood-Brain Barrier Using an In Situ Perfused Rat Brain Model

Weiqing Chen, Jerry Z. Yang, Rikke Andersen et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 51 citations

Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism

Anne Engelbrecht Thomsen, Gerda Marie Friedrichsen, Arne Hagsten Sørensen et al. · Journal of Controlled Release · 2003 · 30 citations · Full text

Caco-2 Cells, Biochemistry, Medicine +6

Model prodrugs for the intestinal oligopeptide transporter: model drug release in aqueous solution and in various biological media

Carsten Uhd Nielsen, Rikke Andersen, Birger Brodin et al. · Journal of Controlled Release · 2001 · 21 citations

Biochemistry, Gastrointestinal Pharmacology, Medicine +6

Development of a QSAR Model for Binding of Tripeptides and Tripeptidomimetics to the Human Intestinal Di-/Tripeptide Transporter hPEPT1

Rikke Andersen, Flemming Steen Jørgensen, Lars Olsen et al. · Pharmaceutical Research · 2006 · 18 citations

Medicinal Chemistry, Biochemistry, Gastrointestinal Pharmacology +8